Merdury Biopharmaceutical Corporation (TPEX:6932)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
7.98
-0.01 (-0.13%)
May 8, 2026, 1:52 PM CST
Market Cap3.37B -38.4%
Revenue (ttm)n/a
Net Income-67.23M
EPS-0.16
Shares Out422.03M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume168,028
Average Volume621,663
Open7.99
Previous Close7.99
Day's Range7.61 - 8.00
52-Week Range4.95 - 13.25
Beta-1.25
RSI48.21
Earnings DateMay 14, 2026

About Merdury Biopharmaceutical

Merdury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development. Merdury Biopharmaceutical Corporation was founded in 2019 and is headquartered in New Taipei C... [Read more]

Sector Healthcare
Founded 2019
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6932
Full Company Profile

Financial Performance

Financial Statements